Short-term effectiveness of HIV care coordination among persons with recent HIV diagnosis or history of poor HIV outcomes
Researchers aimed to better understand how Care Coordination Programs (CCP) affect PLWH by having one group that was a part of a CCP and another that wasn’t. After 12-months individuals, viral loads before and after the study were compared. It was found that those in the CCP who had been recently diagnosed benefited the greatest from the program, so it is hypothesized that CCPs help with the initial hurdles of accessing and adhering to ART.
Reconciling the evaluation of co-morbidities among HIV care patients in two large data systems: the Medical Monitoring Project and CFAR Network of Integrated Clinical Systems
Data on persons with HIV and their burden of disease is poor and varies from one database to another. A study was performed utilizing two large databases, MMP and CNICS. The results displayed that each database can provide reliable data to monitor HIV co-morbidities in the US.
A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study
A cross-sectional study assessed how effective it was for those on HIV meds to not transmit to others, along with how high the loss to follow-up was in various HIV programs. They found that there was a high loss of follow-up in HIV care programs, but it highlighted the need for intervention as well as an increase in rates of viral suppression.
Using registry data to construct a comparison group for programmatic effectiveness evaluation: the New York City HIV care coordination program
To gauge and improve the effectiveness of care coordination programs, researchers looked at CCP evaluations of individuals with HIV. Oftentimes just looking at pre and post-program evaluations do not consider external events in a CCP participant’s life, which has an impact on the effectiveness of the program. Researchers suggest keeping a registry of possible events in the patient’s life. This way, care coordinators can be continuous and mindful of the patient’s circumstances.
HIV and aging: Role of the microbiome
The researchers in this study observe gut bacteria and the microbiome to see its impact on those aging with HIV.
Aging in HIV-Infected Subjects: A New Scenario and a New View
Researchers examine the age-related conditions in older persons with HIV and address clinical management according to the author’s expertise and published literature. The researchers aim to advance the debate about the most appropriate management of this population, including less well-studied aspects, such as the frequency of screening for psychological/mental and social and functional capabilities.
Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care
There is a steep increase in life expectancy for HIV patients who are introduced to ART. HIV-positive individuals also have a higher prevalence than HIV-uninfected individuals of lifestyle risk factors that should be addressed by providers.
Clinical implications of aging with HIV infection: perspectives and the future medical care agenda
With increasing numbers of aging PLWH, HIV care programs need to begin involving geriatric medicine practices. Researchers suggest that an aging HIV+ person’s care should involve a multidisciplinary team that would include primary care physicians, social workers, and geriatricians.
Faces of Frailty in Aging with HIV Infection
The development of frailty is a risk factor for most aging adults however OPWH are at a greater risk of this development. Prevention efforts need to be made to help OPWH successfully age without disability or loss of independence. It also discusses how the needs for OPWH should be evaluated.
A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada
Canada and the United Kingdom have different provisions in health care services for those living with HIV. This study follows Canadians and UK citizens with HIV who started ART between 2000 and 2012. The researchers found that there was no significant difference in mortality rates between Canadians and UK citizens who got HIV through sexual transmission and were on ART.
